Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 26, 2022 at 07:46 am
Share
Shenzhen Bioeasy Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 294 million compared to CNY 146.92 million a year ago. Revenue was CNY 294 million compared to CNY 146.92 million a year ago. Net income was CNY 114.13 million compared to CNY 87.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.23 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.23 a year ago.
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.